Protein-based microarrays are among the novel class of rapidly emerging proteomic technologies that will allow us to efficiently perform global proteome analysis. However, the process of designing adequate protein microarrays is a major inherent problem. In this study, we have evaluated a protein microarray platform based on nonpurified affinity-tagged single-chain (sc) Fv antibody fragments to generate proof-of-principle and to demonstrate the specificity and sensitivity of the array design. To this end, we used our human recombinant scFv antibody library genetically constructed around one framework, the n-CoDeR library containing 2 x 10(10) clones, as a source for our probes. The probes were immobilized via engineered C-terminal affinity ...
Generating proteomic maps of membrane proteins, common targets for therapeutic interventions and dis...
Antibody-based microarray is a novel proteomic technology setting a new standard for molecular profi...
Affinity proteomics, represented by antibody arrays, is a multiplex technology for high-throughput p...
Antibody-based microarray is a novel technology with great potential within high-throughput proteomi...
Antibody-based microarray is a novel technology with great promise within high-throughput proteomics...
Antibody-based microarray is a novel technology with great promise in biomedicine that will provide ...
Antibody-based microarrays are among the novel class of rapidly evolving proteomic technologies. In ...
Antibody-based microarrays are among the novel classes of rapidly evolving proteomic technologies th...
Antibody-based microarrays are a new powerful proteomic technology that can be used to generate rapi...
In recent years, the antibody microarray technology has made significant progress, going from proof-...
Antibody-based microarrays is a novel technology with great promise for high-throughput proteomics. ...
Antibody microarray is a rapidly emerging, powerful approach with great promise within high-throughp...
Abstract The number of cancer and autoimmune disease diagnoses increases in our society, which place...
Antibody-based microarrays are a rapidly emerging technology that has advanced from the first proof-...
Antibody-based microarrays is a rapidly evolving technology that has gone from the first proof-of-co...
Generating proteomic maps of membrane proteins, common targets for therapeutic interventions and dis...
Antibody-based microarray is a novel proteomic technology setting a new standard for molecular profi...
Affinity proteomics, represented by antibody arrays, is a multiplex technology for high-throughput p...
Antibody-based microarray is a novel technology with great potential within high-throughput proteomi...
Antibody-based microarray is a novel technology with great promise within high-throughput proteomics...
Antibody-based microarray is a novel technology with great promise in biomedicine that will provide ...
Antibody-based microarrays are among the novel class of rapidly evolving proteomic technologies. In ...
Antibody-based microarrays are among the novel classes of rapidly evolving proteomic technologies th...
Antibody-based microarrays are a new powerful proteomic technology that can be used to generate rapi...
In recent years, the antibody microarray technology has made significant progress, going from proof-...
Antibody-based microarrays is a novel technology with great promise for high-throughput proteomics. ...
Antibody microarray is a rapidly emerging, powerful approach with great promise within high-throughp...
Abstract The number of cancer and autoimmune disease diagnoses increases in our society, which place...
Antibody-based microarrays are a rapidly emerging technology that has advanced from the first proof-...
Antibody-based microarrays is a rapidly evolving technology that has gone from the first proof-of-co...
Generating proteomic maps of membrane proteins, common targets for therapeutic interventions and dis...
Antibody-based microarray is a novel proteomic technology setting a new standard for molecular profi...
Affinity proteomics, represented by antibody arrays, is a multiplex technology for high-throughput p...